Overview

Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The pharmacokinetics of fluconazole are expected to be different in ICU patients compared to non-ICU patients. The investigators will determine fluconazole and free fluconazole concentrations in 20 ICU patients, who will get intravenous fluconazole as standard care. Switching to oral/enteral fluconazol is allowed after day 3. A full pharmacokinetic curve will be taken on day 3 of iv therapy and limited pharmacokinetic curves on day 7 of iv therapy and/or on day 3 of oral therapy; trough levels will be taken daily after intravenous therapy.
Details
Lead Sponsor:
Radboud University
Treatments:
Fluconazole